Nemours Children’s Hospital, Delaware is seeking a full-time Medical Director of Apheresis with experience in cellular therapy collection and processing for a rapidly growing cell and gene therapy program. The successful candidate will play an integral role in the growth and expansion of the NCH-DE Apheresis Program in collaboration with the Division of Transplant and Cellular Therapy and Division of Pathology and Clinical Laboratory. As Medical Director of Apheresis, the candidate will oversee all existing therapeutic and clinical apheresis services including plasmapheresis and erythrocytapheresis. Responsibilities also include the development of a comprehensive cellular collections service and participation in advancing Stem Cell Laboratory processes to meet the growing demand for cellular and gene therapies. The NCH-DE offers patients advanced therapeutic products including CAR-T and gene therapies for sickle cell disease and thalassemia as well as clinical trials that extend novel therapies to patients including cord blood transplant for cerebral palsy and a SCIDS trial using TCR αβ/CD19 depleted grafts. 

This position offers an excellent opportunity to contribute to a rapidly expanding and well supported program, and substantial potential for professional growth. The Medical Director of Apheresis will work closely with the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders team as we work to offer our patients state-of-the-art treatments. The Lisa Dean Moseley Foundation gifted $78 million to lead NCH-DE to national prominence in cancer and blood disorders. Nemours Children's and the Moseley Foundation Institute are committed to providing state-of-the-art patient care including transformative therapies. 

Interested candidates should forward their formal CV to:

Marietta Lundberg, Administrative Director

Nemours Children’s Health

Marietta.Lundberg@nemours.org

Opportunities and Expectations for Leadership 

• MD/DO degree
• Board Certified in Pediatrics/Hematology & Oncology, Clinical Pathology, or Anatomic and Clinical Pathology
• Additional Board Certification/eligibility/specialization in Transfusion Medicine preferred
• Demonstrated expertise in Apheresis 

About Nemours Children’s Health

Nemours Children’s Health is an internationally recognized children’s health system. With more than 1.7 million patient encounters annually, Nemours provides medical care in five states through two freestanding state-of-the-art children’s hospitals — Nemours Children’s Hospital, Delaware and Nemours Children’s Hospital, Florida. Nemours’ pediatric network includes 80 primary-urgent-and specialty care practices and more than 40 hospitalists serving 19 affiliated hospitals. Nemours generates annual revenues of more than $1.7 billion derived from patient services, contributions from the Alfred I. duPont Trust, as well as other income. Nemours is an open and welcoming place to work, and values diversity in all its forms. 

As the birthplace of the Nemours healthcare system, Nemours Children’s Hospital, Delaware honors our legacy of delivering exceptional care to the children of the Delaware Valley and beyond. Ranked among the nation’s best pediatric hospitals by U.S. News & World Report and honored with the ANCC’s Magnet® Designation for excellence in nursing practice, we offer intensive and acute inpatient and outpatient services covering more than 30 pediatric specialties. Additionally, Nemours Children’s Health Primary Care allows us to reach more children across the region through community-based physician services and collaborative partnerships with health and hospital systems. 

Nemours Children's Health is ranked as one of the country's Best Children's Hospitals and the Nemours Center for Cancer and Blood Disorders is ranked as one of the country's Top Pediatric Cancer Centers as per US News & World Report. This excellence is mostly accredited to their excellent rankings in five-year cancer survival, post bone marrow transplant survival, advanced clinical services and treatment and exceptional nursing and clinical support services. More than just a new name, the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders will drive new opportunities for pediatric cancer and blood disorder care at Nemours Children's Health. The foundation has pledged a $78 million donation in the support of new programs including an internal and external grants programs that will improve ways to treat pediatric cancer and blood disorders. 

Additional information can be found at: https://www.nemours.org/well-beyond-medicine/the-moseley-institute.html.